Video

December 9, 2014

New Jersey Screening Program Helps Find Heart Defects Early Part 2

Author(s):

In the second part of an interview with Kim Van Naarden Braun, PhD, the screening process used in New Jersey is discussed at the national level.

In the second part of an interview with Kim Van Naarden Braun, PhD, the screening process used in New Jersey is discussed at the national level.

Related Videos

New ‘Level Up’ Data on Upadacitinib (Rinvoq) for Atopic Dermatitis, with Christopher Bunick, MD, PhD

Julie Refardt, MD, PhD: Current Hyponatremia Clinical Interventions Sufficient

Richard Pratley, MD | Credit: Advent Health Diabetes Institute

Christopher Bunick, MD, PhD: Facts About Systemic Therapies’ Safety, Mechanism of Action

Carla Nester, MD | Credit: HCPLive

Shawn Kwatra, MD: Making the Connection Between Prurigo Nodularis, Atopic Dermatitis, and Itch

Will Herrington, MBBS, MD, MA: Empagliflozin Follow-up Data Informs Clinical Care for CKD

Jennifer Lai Yee, MD, PhD, MPH: Honing in on Sparsentan’s Benefit in Genetic FSGS

Highlighting Recent Therapies for Dermatologists, with James Del Rosso, DO

$Ladan Zand, MD: Obinutuzumab Promising Option for Refractory, Primary FSGS$

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences

All rights reserved.